Filing Details
- Accession Number:
- 0001209191-21-033402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 11:36:39
- Reporting Period:
- 2021-05-17
- Accepted Time:
- 2021-05-18 11:36:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363812 | Molly Henderson | C/O Urogen Pharma Ltd. 400 Alexander Park Drive Princeton NJ 08540 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-17 | 2,500 | $15.85 | 2,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
